Science Explorer Interactive view Map
Company · Champaign · United States

Aptimmune Biologics (United States)

Research works
2
▲ 315% vs 2013–17
Citations
46
30.1 per fractional work
Top-10% rate
34.6%
record average 16.5%
Open access
54%
world 28%

Not ranked overall: Aptimmune Biologics (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which research topics does Aptimmune Biologics (United States) publish most on?

By volume: Animal Virus Infections Studies, Viral gastroenteritis research and epidemiology, SARS-CoV-2 and COVID-19 Research and Virus-based gene therapy research.

  1. 1 Animal Virus Infections Studies Animal Science and Zoology 0 works
  2. 2 Viral gastroenteritis research and epidemiology Infectious Diseases 0 works
  3. 3 SARS-CoV-2 and COVID-19 Research Infectious Diseases 0 works
  4. 4 Virus-based gene therapy research Genetics 0 works
  5. 5 Animal Disease Management and Epidemiology Agronomy and Crop Science 0 works
  6. 6 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 0 works
  7. 7 Vector-Borne Animal Diseases Ecology, Evolution, Behavior and Systematics 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available54.3%not open45.7%

World: 28% of research is openly available.

with international co-authors21.7%domestic only78.3%

World: 19% is written across borders.

How has Aptimmune Biologics (United States)'s research output changed?

Output in 2018–2022 was 315% higher than in 2013–2017.

20152020

Other research institutions in Champaign

All research institutions in Champaign

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.